Literature DB >> 20945262

All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving.

Dana Katz1, Arthur L Caplan, Jon F Merz.   

Abstract

Much attention has been focused in recent years on the ethical acceptability of physicians receiving gifts from drug companies. Professional guidelines recognize industry gifts as a conflict of interest and establish thresholds prohibiting the exchange of large gifts while expressly allowing for the exchange of small gifts such as pens, note pads, and coffee. Considerable evidence from the social sciences suggests that gifts of negligible value can influence the behavior of the recipient in ways the recipient does not always realize. Policies and guidelines that rely on arbitrary value limits for gift-giving or receipt should be reevaluated.

Mesh:

Year:  2010        PMID: 20945262     DOI: 10.1080/15265161.2010.519226

Source DB:  PubMed          Journal:  Am J Bioeth        ISSN: 1526-5161            Impact factor:   11.229


  18 in total

1.  Pharmacists' Perceptions of the Influence of Interactions with the Pharmaceutical Industry on Clinical Decision-Making.

Authors:  Aaron M Tejani; Peter Loewen; Richard Bachand; Curtis K Harder
Journal:  Can J Hosp Pharm       Date:  2015 Sep-Oct

2.  Physician-Industry Interactions and Anti-Vascular Endothelial Growth Factor Use Among US Ophthalmologists.

Authors:  Stanford C Taylor; Julia B Huecker; Mae O Gordon; David E Vollman; Rajendra S Apte
Journal:  JAMA Ophthalmol       Date:  2016-08-01       Impact factor: 7.389

3.  Dissemination, adoption, and implementation of acamprosate for treating alcohol use disorders.

Authors:  Hannah K Knudsen; Paul M Roman
Journal:  J Stud Alcohol Drugs       Date:  2014-05       Impact factor: 2.582

4.  Sorrell v. IMS Health: issues and opportunities for informaticians.

Authors:  Carolyn Petersen; Paul Demuro; Kenneth W Goodman; Bonnie Kaplan
Journal:  J Am Med Inform Assoc       Date:  2012-10-27       Impact factor: 4.497

5.  Industry involvement in continuing medical education: time to say no.

Authors:  Sheryl Spithoff
Journal:  Can Fam Physician       Date:  2014-08       Impact factor: 3.275

6.  The transition to medication adoption in publicly funded substance use disorder treatment programs: organizational structure, culture, and resources.

Authors:  Hannah K Knudsen; Paul M Roman
Journal:  J Stud Alcohol Drugs       Date:  2014-05       Impact factor: 2.582

7.  The ethical challenges in rheumatology.

Authors:  Emily J Mckeown
Journal:  Curr Rev Musculoskelet Med       Date:  2015-06

8.  Active Learning to Promote Early and Effective Physician Interaction with Pharmaceutical Industry Marketing Practices.

Authors:  Elan Baskir; Gagani Athauda; Golsheed N Zeiarati; Sanaz B Kashan; Eduardo Camps-Romero; Marin Gillis
Journal:  Med Sci Educ       Date:  2020-04-22

9.  The relationship between paediatric practitioners and 'industry'.

Authors:  Susan Albersheim; Kevin Coughlin
Journal:  Paediatr Child Health       Date:  2017-08-11       Impact factor: 2.253

10.  Potential Conflict of Interest and Bias in the RACGP's Smoking Cessation Guidelines: Are GPs Provided with the Best Advice on Smoking Cessation for their Patients?

Authors:  Ross MacKenzie; Wendy Rogers
Journal:  Public Health Ethics       Date:  2015-04-20       Impact factor: 1.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.